Nephrocare Health Services profit and loss

Latest FY26

Revenue: ₹999cr
EBITDA: ₹227cr
Net profit: ₹76.8cr
EPS: ₹8.48

₹ crore except per share

Tap a line for its trend	FY26Mar 2026

Expenses
	999
	24.5
	1,023
	227
	172
	60.2
	90.7
	373
	923
	227
	136
Profit
	101
	101
	35.6
	−14.9
	20.6
	−3.1
	76.8
	79.9
	18.6
	95.5
	76.8
Per share
	₹8.48
	₹8.10
Other comprehensive income — detail
	18.6
	0.1
	18.6
	95.5
Per share — as-filed variants
	₹8.48
	₹8.10
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	772
	77.3%
Adjusted (ex-exceptional items) — derived
	101
	76.8
	₹8.48

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEPHROPLUS₹628.55

Nephrocare Health Services Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersKRSNAA SURAKSHA HEALTHX 3BBLACKBIOMcap ₹6,307 Cr

View

	In ₹ Crore except Per Share 12 Months Ending	FY26 31/03/2026
	Revenue from Operations	998.8
	Other Income	24.5
	Total Income	1,023.4
	Expenses
	+ Cost of Materials Consumed	226.8
	+ Employee Benefit Expense	171.8
	+ Finance Costs	60.2
	+ Depreciation & Amortisation	90.7
	+ Other Expenses	373.3
	Total Expenses	922.8
	EBITDA	227.0
	EBIT	136.3
	Profit
	PBT before Exceptional Items	100.6
	Pretax Income	100.6
	+ Current Tax	35.6
	+ Deferred Tax	-14.9
	Tax Expense	20.6
	+ Share of Associates & JVs	-3.1
	Net Income	76.8
	+ Net Income — Continuing Ops	79.9
	+ Other Comprehensive Income	18.6
	Total Comprehensive Income	95.5
	Net Income to Common	76.8
	Per Share
	Basic EPS	8.48
	Diluted EPS	8.10
	Other Comprehensive Income — detail
	+ Other Comprehensive Income	18.6
	+ Items NOT to be Reclassified to P&L	0.1
	+ Items to be Reclassified to P&L	18.6
	Comprehensive Income — Owners of Parent	95.5
	Per Share — as-filed variants
	Basic EPS — Continuing Operations	8.48
	Diluted EPS — Continuing Operations	8.10
	Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
	Gross Profit	772.1
	Gross Margin %	77.29
	Adjusted (ex-Exceptional Items) — derived
	Pretax Income (Adjusted, as filed)	100.6
	Net Income Adj (tax-effected)	76.8
	EPS Adj	8.48
	Other Filed Concepts — mapped but not yet placed in the schedule
	Face Value	2.00
	Paid Up Equity Capital	20.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.